why choose us

First received: February 21, 2025

Clinical Trial: A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: RSV Infection

Study Type: INTERVENTIONAL


Official Title: A Non-Randomized, Open-Label, Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine, and Fluconazole on the Pharmacokinetics and Safety of EDP-323 in Healthy Pa

Brief Summary: The primary aim of the study is to assess the effect of itraconazole, carbamazepine, quinidine, and fluconazole individually on the pharmacokinetics and safety of EDP-323 in healthy adult participants.Each participant's duration in the study will be dependent upon which study part they are enrolled.

Read more